1. Isis Plans to Commercialize Own Drugs

    Isis Pharmaceuticals, a Carlsbad-based company pioneering in antisense drug discovery, announced they will offer $425 million of convertible senior notes due in 2021. The biotech company, which has several drugs in the development pipeline, has always focused on the research and early development stage before recruiting a marketing partner.

1 Item

To Top